Concepedia

TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells

Liang Mao, Yao Xiao, Qi‐Chao Yang, Shao‐Chen Yang, Leilei Yang, Zhi‐Jun Sun

Oral Oncology · 2021 · 63 citations · 26 references

DOI

Concepts

References

26

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

, , +16

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Robert L. Ferris, George R. Blumenschein, Jérôme Fayette et al. · New England Journal of Medicine · 2016 · 5.1K citations · Full text

, , +5

Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0

Nathalie Percie du Sert, Amrita Ahluwalia, Sabina Alam et al. · PLoS Biology · 2020 · 2.8K citations · Full text

, , +8

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Dirk Schadendorf, F. Stephen Hodi, Caroline Robert et al. · Journal of Clinical Oncology · 2015 · 2.1K citations · Full text

, , +17

The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells

Xin Yu, Kristin Harden, Lino C. Gonzalez et al. · Nature Immunology · 2008 · 1.5K citations

, , +15